Editorial: the EMA success story...so far
This article was originally published in Scrip
Readers may have noticed that this month we have published a series of articles on the theme of "The EMA at 20". They culminated on 18 March in the publication of an exclusive supplement by Scrip Intelligence and its sister publication Scrip Regulatory Affairs to mark the 20th anniversary of the European Medicines Agency.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.